Stay updated on EPCORE™ NHL-1 Clinical Trial
Sign up to get notified when there's something new on the EPCORE™ NHL-1 Clinical Trial page.

Latest updates to the EPCORE™ NHL-1 Clinical Trial page
- CheckyesterdayChange DetectedNIH Grant/Contract entries for 2017 and 2023 were added to the funding information. The Revision: v3.6.6 entry indicates the page was updated from the prior v3.6.5.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new citation was added to the Publications section, listing authors and the article about epcoritamab dosing and CRS risk mitigation. This broadens the study's referenced literature in the context of ongoing research.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded a new publication citation (Sinnollareddy et al.) related to epcoritamab to the study publications. The page version was updated to v3.6.5, and older July entries were removed to refresh the publication and version history.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, indicating a maintenance release of the site's underlying framework. This does not modify the study details or clinical data presented on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study record's update dates were refreshed with July 2026 entries, replacing June 2026 dates. This appears to be routine maintenance of the page rather than modifications to the trial details.SummaryDifference0.1%

- Check59 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3. This appears to be a minor software update to the page rather than a change to study information.SummaryDifference0.0%

Stay in the know with updates to EPCORE™ NHL-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPCORE™ NHL-1 Clinical Trial page.